Showing results (61-70 of 575) with videos related to

Sort By:
Pageof 58
Autoimmunity Reviews|October 23, 2019
Is there today a place for corticosteroids in the treatment of scleroderma?Jelena Blagojevic, Paul Legendre, Marco Matucci-Cerinic, et al.
Frontiers in Medicine|September 13, 2023
Relationship between paramacular thinning, cerebral vasculopathy, and hematological risk factors in sickle cell diseaseChristophe Orssaud, Edouard Flamarion, Adrien Michon, et al.
Retina (Philadelphia, Pa.)|November 10, 2023
ATYPICAL FOVEAL AND PARAFOVEAL ABNORMALITIES IN SICKLE CELL DISEASEChristophe Orssaud, Edouard Flammarion, Adrien Michon, et al.
Current Rheumatology Reports|November 10, 2010
The scleroderma kidney: progress in risk factors, therapy, and preventionGuillaume Bussone, Alice Bérezné, Vincent Pestre, et al.
Autoimmunity Reviews|July 6, 2015
Implication of B lymphocytes in the pathogenesis of ANCA-associated vasculitidesNicolas Dumoitier, Benjamin Terrier, Jonathan London, et al.
Presse Medicale (Paris, France : 1983)|January 9, 2009
[Tuberculosis risk among patients with systemic diseases]Mona Ben m'rad, Dalenda Gherissi, Luc Mouthon, et al.
The Journal of Rheumatology|May 9, 2008
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label studyAlice Bérezné, Brigitte Ranque, Dominique Valeyre, et al.
Presse Medicale (Paris, France : 1983)|March 27, 2007
[Antileukotrienes and Churg-Strauss syndrome]Philippe Guilpain, Christian Pagnoux, François Lhote, et al.
Joint Bone Spine|September 29, 2020
Ethnic influence on the phenotype of French patients with systemic sclerosisAlexia Steelandt, Nouria Benmostefa, Jérôme Avouac, et al.
Autoimmunity Reviews|May 12, 2010
Pathogenesis of giant cell arteritis: More than just an inflammatory condition?Kim-Heang Ly, Alexis Régent, Mathieu C Tamby, et al.
Pageof 58